Sage Journals: Discover world-class research

Retricted access

Research article

First published 1983-9

Liability Claims Based on Drug Use

Joseph L. Fink

Annals of Pharmacotherapy

Retricted access

Research article

First published 1991-7

Classifying improvements to drug marketing and justifications for claims of efficacy

Peter R. Mansfield

International Journal of Risk & Safety in Medicine

Retricted access

Research article

First published 1995-1

Supporting Your Claims: Recent Issues in Cardiovascular Drugs

Shaw T. Chen

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1983-7

FDA Approval of Comparative Claims for Prescription Drugs-The Moxam Case

Daniel Marcus

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1998-3

Claims-Making and the Prosecution of Black Defendants in Drug Trafficking Trials: the Influence of Deprivation

Anita Kalunta-Crumpton

International Journal of Discrimination and the Law

Retricted access

Research article

First published 2014-8

Characteristics of judicialization of health in relation to drugs

Salamano Mercedes, Bianchi Mariela, Galati Elvio

Pharmaceuticals Policy and Law

Open access

Research article

First published 2018-10

Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination

Annika M. Jödicke, Ivanka Curkovic, Urs Zellweger [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 1988-7

Impact of Unrecognized Dosing Errors on the Cost and Effectiveness of Pharmaceuticals

John Urquhart, Cynthia Chevalley

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2021-12

Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019

Kimberly G. Wagoner, Allison J. Lazard, E. Alfonso Romero-Sandoval [...]

Cannabis & Cannabinoid Research

Retricted access

Research article

First published 2024-5

Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data

Astrid M Manuel, Assaf Gottlieb, Leorah Freeman [...]

Multiple Sclerosis Journal

Search results